Von Eschenbach Nomination - More Trouble
Update by Lee Bechtel, NHF Lobbyist
September 18, 2006

 

Update September 20, 2006

Von Eschenbach’s nomination was approved by the committee on voice vote. This confirmation now moves to the full U.S. Senate for consideration.

 

 

It is the old line of “Its not over until its over”. 

After stalling for several weeks, the Senate Health, Education, Labor and Pensions (HELP) Committee is scheduled to vote on the nomination of Andrew von Eschenbach to be the next Commissioner of the Food and Drug Administration (FDA) on Wednesday, September 20th.

However, two Republican Senators have told the New York Times (see attached) that they will put a hold on a full Senate vote on the nomination if approved. Senator David Vitter (R-LA) wants the FDA to legalize any form of prescription drug reimportation from Canada, or authorize a pilot program. Senator Jim DeMint (R-SC) wants the FDA to withdraw the abortion drug RU-486 from the market. Neither of these Senators serve on the HELP Committee, unlike Senators Clinton (D-NY) and Patti Murray (D-WA) who put a hold on consideration of the nomination because of the FDA's handling of the “Plan B” emergency contraception pill, for over a year. This was recently resolved leading to the expectation that von Eschenbach would be the next permanent head of the FDA,

Even if the HELP Committee approves von Eschenbach, a hold by either Vitter or DeMint will prevent a full Senate vote this year given the remaining time left on the Congressional calendar. HELP Committee Ranking Member Senator Edward Kennedy (D-MA) has signaled his support for von Eschenbach, which suggests the confirmation will clear the committee on Wednesday.

Once voted out of the committee, but not acted on by the full Senate, President Bush can make a recess appointment to make von Eschenbach the FDA Commissioner. This would be a promotion from the current Acting Commissioner status, but does not carry permanent status. With Congress in recess until mid January 2007, a recess appointment made, for example, in early January carries over into the next Congress. This would mean that von Eschenbach would hold the Commissioner position only until the end of the next Congress, at the end of 2008, unless there is a change in political party leadership in the Senate this year, or people otherwise change their minds.

 

Click the following to see the New York Times article:

2 Republicans in Senate Vow to Block F.D.A. Pick

 

 

 

 

 

 

 

 

 
 



 

 

Hit Counter